TORONTO, Sept. 9, 2024 /CNW/ - Catalytic Health and Bedford Group Transearch are proud to announce the inaugural Canadian Life Sciences Top 20 Under 40 Awards. The new awards will recognize 20 Life Sciences leaders making an outsized impact in their industry and...
Enhancing Board Diversity: Defining DEI Governance Strategy
As corporations strive for greater boardroom diversity, the progress, while commendable, reveals underlying disparities that merit closer examination. Drawing upon industry reports and trends, including insights from both: Bedford Group Transearch’s 2023 Mining...
Biotech Executive Meenu Chhabra Karson joins Bedford Group Transearch Advisory Board
CAMBRIDGE, Mass. and TORONTO, Jan. 30, 2024 /CNW/ - Bedford Group Transearch Life Sciences is pleased to announce the appointment of Meenu Chhabra Karson to their North American Healthcare Advisory Board. Karson will join a group of accomplished leaders from across...
Uncharted Waters and New Horizons: Mapping Healthcare and the Life Sciences for 2024
The Healthcare and Life Sciences sectors are undergoing a seismic shift, propelled by transformative technologies like AI, genomics, and the Internet-of-Things. These innovations will democratize healthcare, enhance diagnostic accuracy, and usher in an era of...
TRANSEARCH International has chosen Décarie Executive Search to establish its presence in Montréal under the new brand name Décarie Transearch
Montreal, Septembre 25, 2023 – TRANSEARCH International, one of the top 10 executive search firms in the world, establishes its presence in Montreal through a new business partnership with Décarie Executive Search. Décarie Transearch now becomes a leader in executive...
Disrupting the Downturns
Economic slumps as an opportunity to build stronger organizations and amplify value.It’s easy to get caught up in the momentum of bad news. There’s a tipping point for the amount of sour notes we can listen to before the whole song takes on a gloomy vibe. Economic...
Strong Life Signs for the Life Sciences
Thriving from a recessionary footing means seizing opportunities from a sector’s bearish cycle READ TIME - 7 MIN. Our outlook for Healthcare and the Life Sciences is as bullish as ever. But recent trends might lead some to feel otherwise. For the sector that has long...
The 2022 Report- Board & Executive Compensation in the Biotech Industry
Bedford Group Transearch Life Sciences today announced their annual publication of The 2022 Executive & Board Compensation Report in the Biotechnology industry. This report details findings from an analysis of compensation composition and earnings for Named...
The Bedford Report 2022- Chief Financial Officer Compensation in the Medtech Industry
The NEW 2022 Bedford Group Transearch Report on Chief Financial Officer Compensation in the Medtech Industry is now available for download. This report is an industry-wide survey of compensation awards and practices for CFOs in the sector, focusing on micro, small and...
The Bedford Report 2022- Board of Directors Compensation in the Medtech Industry
The NEW 2022 Bedford Group Transearch Report on Board of Directors Compensation in the Medtech Industry is now available for download. This report is Bedford’s first annual industry-wide survey of compensation awards and practices in the sector, focusing on micro,...
The Bedford Report 2022- Chief Executive Officer Compensation in the Medtech Industry.
The NEW 2022 Bedford Group Transearch Report on CEO Compensation in the Medtech Industry is now available for download. This report is Bedford's first annual industry-wide survey of compensation awards and practices in the sector, focusing on micro, small and mid-cap...
The Bedford Report 2021- Board & Executive Compensation in the Cannabis Industry.
The 2021 Bedford Group Transearch Report on Board and Executive Compensation in the Cannabis Industry is now available for download. This is an industry-wide survey of compensation awards and practices for C-level executives and board members, and provides insights...